Transactions
| Title | Main Street Resources |
|---|---|
| Type | AAI Mandates |
| Category | Federal Contractor - Design & Manufacturing |
| Subcategory | M&A Buy-Side |
| Details | AAI acted as a buy-side advisor to Main Street Resources in their acquisition of Protective Armored Systems (PAS). Founded in 1993 and headquartered in Lee, MA, PAS is a specialty fabricator of ballistics glass for the government and private sectors. PAS is an expert in glass and polymer lamination, specializing in customized bullet-resistant and security glazing fabrication. Customers include government, law enforcement, architects, business and private individuals. |
| Title | Graceway Pharmaceuticals, LLC |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Sell-Side Equity Financing |
| Details | AAI provided business advisory services in developing the business model that resulted in an equity financing transaction, in the amount of $200 million, involving GTCR Golder Rauner, LLC; a private equity firm that manages more than $8 billion in equity and mezzanine capital invested in a wide range of companies and industries, and Jefferson Gregory, co-founder of King Pharmaceuticals to form Graceway Pharmaceuticals, LLC; a specialty pharmaceutical company that focuses on bringing branded prescription products to the U.S. market through acquisition, in-licensing, and product development. Subsequently, Graceway made its first acquisition by acquiring 3M's branded pharmaceutical business in the U.S., Puerto Rico, Canada and Latin America in a transaction valued at $875 million. |
| Title | Colliers International Property Consultants, Inc. and PharmaBioSource, Inc. |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Divestiture Sell-Side |
| Details | Advisory Associates acted as advisor to both Colliers International Property Consultants, Inc., a globally affiliation of independently owned commercial real estate firms totaling more than 10,000 employees and spanning the world in more than 260 offices in 57 countries; and PharmaBioSource, Inc., a pharmaceutical and biotechnology capacity, transaction and consulting service company; in a transaction valued at $100 million involving the divestiture of an operating pharmaceutical facility, which included the legacy products manufactured there and the related contract manufacturing business. |
| Title | Citigroup, Inc. |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Sell-Side Debt Financing |
| Details | Advisory Associates acted as advisor to Citigroup - Global Healthcare Group, a division of Citigroup's Global Capital Markets, in a transaction involving the placement of $400 million in convertible debt for a publicly traded pharmaceutical company. |
| Title | Stellar Pharmaceuticals, Inc. |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Sell-Side Licensing |
| Details | Advisory Associates served as the exclusive advisor to Stellar Pharmaceuticals, Inc., a company that develops high quality, cost effective proprietary products based on its core polysaccharide technology for niche, under-served markets, in a transaction involving the licensing rights and related supply agreement of its product Uracyst ®, Stellar’s novel agent for the treatment of interstitial cystitis, to Watson Pharmaceuticals, Inc. |
| Title | PreMD, Inc. |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Sell-Side Licensing |
| Details | Advisory Associates served as the exclusive advisor to PreMD, Inc., a world leader in predictive medicine, in a transaction involving the licensing rights for the U.S. marketing and distribution of its novel non-invasive skin cholesterol test, currently marketed as PREVU - that helps assess an individual’s risk of coronary heart disease, to AstraZeneca Pharmaceuticals LP. |
| Title | PRA International, Inc. and The Emmes Corporation |
|---|---|
| Type | AAI Mandates |
| Category | Healthcare Services |
| Subcategory | Clinical Advisory |
| Details | Advisory Associates provided AAI Mandates services to PRA International, Inc., one of the world’s leading global clinical development organizations with more than 3000 employees worldwide, and The Emmes Corporation, a contract research organization dedicated to providing statistical and epidemiological expertise and other overall operational support services to clients engaged in clinical and biomedical research, in a transaction involving the clinical development of a novel Age related Macular Degeneration (AMD) molecule. |
| Title | Middlebrook Pharmaceuticals, Inc. (formerly Advancis Pharmaceutical, Inc.) and Lehman Brothers, Inc. |
|---|---|
| Type | AAI Mandates |
| Category | Biotech |
| Subcategory | Equity Financing |
| Details | Advisory Associates provided AAI Mandates services to Lehman Brothers related to the Initial Public Offering of Advancis, a pharmaceutical company focused on developing and commercializing anti-infective drug products utilizing its proprietary, once-a-day pulsatile drug delivery technology, PULSYS. |
| Title | Leitner Pharmaceuticals, LLC |
|---|---|
| Type | AAI Mandates |
| Category | Pharmaceuticals |
| Subcategory | Business Advisory Buy-Side |
| Details | Advisory Associates provides ongoing business advisory consulting and strategy assessments to Leitner Pharmaceuticals, LLC, a wholly owned subsidiary of SJ Strategic Investments, related to business development opportunities. |